drug

COM701

1 story · latest Aug 3, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Compugen Ltd

Timeline

Compugen reports Q2 2026 results, cash runway extended into 2029

Aug 3Quarterly updateCompugen Ltd

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.